Journal List > J Korean Ophthalmol Soc > v.57(10) > 1010421

Na, Shin, Lee, Kim, and Lee: Incidence of Posterior Capsular Opacification Based on Low and High Fluid-dynamic Parameters

Abstract

Purpose

To compare the incidence of posterior capsular opacification (PCO) based on low and high fluid-dynamic parameters during cataract surgery and evaluate the importance of these findings.

Methods

This retrospective study included 125 eyes in 73 patients with senile cataract who received a cataract surgery between September 2013 and March 2014. Patients were divided into 2 groups: those with low (vacuum: 180 mm Hg, aspiration flow: 18 mL/min, bottle height: 55 cm) and high (vacuum: 400 mm Hg, aspiration flow: 22 mL/min, bottle height: 90 cm) fluidic parameters during the nucleus was removal. We measured the total surgery time, ultrasound time, and balanced salt solution consumption during phacoemulsification. Best corrected visual acuity (BCVA), PCO score, PCO percentage and severity were measured at 3, 6 and 12 months postoperatively. Endothelial cell density (ECD) was measured preoperatively and 12 months postoperatively.

Results

The study included 20 eyes of 13 patients with low parameters and 20 eyes of 15 patients with high parameters. There was no statistically significant difference in the mean total surgery time, ultrasound time or fluid consumption between the two groups. BCVA and ECD were not significantly different between the two groups during the postoperative follow-up. PCO score, percentage and severity were higher in the low parameter group at 3, 6 and 12 months postoperatively.

Conclusions

Surgery with low fluid-dynamic parameters is equally effective as with high parameters in terms of surgical time and postoperative BCVA. However, the incidence of PCO was higher in the low fluid-dynamic parameter group up to 12 months. Surgical efforts to reduce remnant lens epithelial cells are needed during low fluidic-dynamic parameter surgery.

References

1. Kelman CD. The history and development of phacoemulsification. Int Ophthalmol Clin. 1994; 34:1–12.
crossref
2. Fine IH, Packer M, Hoffman RS. Power modulations in new abdominal technology: improved outcomes. J Cataract Refract Surg. 2004; 30:1014–9.
3. Vasavada AR, Raj S. Step-down technique. J Cataract Refract Surg. 2003; 29:1077–9.
crossref
4. Ward MS, Georgescu D, Olson RJ. Effect of bottle height and aspiration rate on postocclusion surge in Infiniti and Millennium peri-staltic phacoemulsification machines. J Cataract Refract Surg. 2008; 34:1400–2.
crossref
5. Heo WJ, Lee JY, Kim HK. Comparison of clinical outcomes abdominal high and low fluid-dynamic parameters during phacoemulsification. J Korean Ophthalmol Soc. 2015; 56:1860–6.
6. Oh TH, Lee SJ, Kim HS. Clinical outcomes of cataract surgery abdominal torsional mode phacoemulsification and soft shell technique. J Korean Ophthalmol Soc. 2009; 50:1313–8.
7. Lee JE, Choi SH. Comparison of clinical results between ellips and ozil modes in phacoemulsification. J Korean Ophthalmol Soc. 2011; 52:1161–6.
crossref
8. Awasthi N, Guo S, Wagner BJ. Posterior capsular opacification: a problem reduced but not yet eradicated. Arch Ophthalmol. 2009; 127:555–62.
9. Apple DJ, Peng Q, Visessook N, et al. Eradication of posterior abdominal opacification: documentation of a marked decrease in Nd:YAG laser posterior capsulotomy rates noted in an analysis of 5416 pseudophakic human eyes obtained postmortem. Ophthalmology. 2001; 108:505–18.
10. Nishi O, Nishi K, Sakka Y, et al. Intercapsular cataract surgery with lens epithelial cell removal. Part IV: Capsular fibrosis induced by poly(methyl methacrylate). J Cataract Refract Surg. 1991; 17:471–7.
11. Sterling S, Wood TO. Effect of intraocular lens convexity on abdominal capsule opacification. J Cataract Refract Surg. 1986; 12:655–7.
12. Born CP, Ryan DK. Effect of intraocular lens optic design on abdominal capsular opacification. J Cataract Refract Surg. 1990; 16:188–92.
13. Legler UF, Apple DJ, Assia EI, et al. Inhibition of posterior capsule opacification: the effect of colchicine in a sustained drug delivery system. J Cataract Refract Surg. 1993; 19:462–70.
crossref
14. Power WJ, Neylan D, Collum LM. Daunomycin as an inhibitor of human lens epithelial cell proliferation in culture. J Cataract Refract Surg. 1994; 20:287–90.
crossref
15. Kim NE, Lee SJ, Park JM. Risk factors for development of abdominal capsule opacification after cataract surgery or combined abdominal surgery. J Korean Ophthalmol Soc. 2014; 55:1132–8.
16. Findl O, Buehl W, Siegl H, Pinz A. Removal of reflections in the photographic assessment of PCO by fusion of digital retro-illumination images. Invest Ophthalmol Vis Sci. 2003; 44:275–80.
crossref
17. Findl O, Buehl W, Menapace R, et al. Comparison of 4 methods for quantifying posterior capsule opacification. J Cataract Refract Surg. 2003; 29:106–11.
crossref
18. Camparini M, Macaluso C, Reggiani L, Maraini G. Retroillumination versus reflected-light images in the photographic abdominal of posterior capsule opacification. Invest Ophthalmol Vis Sci. 2000; 41:3074–9.
19. Bender L, Spalton DJ, Uyanonvara B, et al. POCOman: new abdominal for quantifying posterior capsule opacification. J Cataract Refract Surg. 2004; 30:2058–63.
20. Barman SA, Hollick EJ, Boyce JF, et al. Quantification of posterior capsular opacification in digital images after cataract surgery. Invest Ophthalmol Vis Sci. 2000; 41:3882–92.
21. Wong T, Hingorani M, Lee V. Phacoemulsification time and power requirements in phaco chop and divide and conquer nucleofractis techniques. J Cataract Refract Surg. 2000; 26:1374–8.
crossref
22. Verges C, Cazal J, Lavin C. Surgical strategies in patients with abdominal and glaucoma. Curr Opin Ophthalmol. 2005; 16:44–52.
23. Hayashi K, Hayashi H, Nakao F, Hayashi F. Risk factors for abdominal endothelial injury during phacoemulsification. J Cataract Refract Surg. 1996; 22:1079–84.
24. Faramarzi A, Javadi MA, Karimian F, et al. Corneal endothelial cell loss during phacoemulsification: bevel-up versus bevel-down phaco tip. J Cataract Refract Surg. 2011; 37:1971–6.
crossref
25. Osher RH. Slow motion phacoemulsification approach. J Cataract Refract Surg. 1993; 19:667.
crossref
26. Hayashi K, Yoshida M, Manabe S, Hirata A. Cataract surgery in eyes with low corneal endothelial cell density. J Cataract Refract Surg. 2011; 37:1419–25.
crossref
27. Wong MM, Shukla AN, Munir WM. Correlation of corneal abdominal and volume with intraoperative phacoemulsification parame-ters using Scheimpflug imaging and optical coherence tomography. J Cataract Refract Surg. 2014; 40:2067–75.
28. Walkow T, Anders N, Klebe S. Endothelial cell loss after abdominal: relation to preoperative and intraoperative parameters. J Cataract Refract Surg. 2000; 26:727–32.
29. Nixon DR. Preoperative cataract grading by Scheimpflug imaging and effect on operative fluidics and phacoemulsification energy. J Cataract Refract Surg. 2010; 36:242–6.
crossref
30. Vasavada AR, Praveen MR, Vasavada VA, et al. Impact of high and low aspiration parameters on postoperative outcomes of abdominal: randomized clinical trial. J Cataract Refract Surg. 2010; 36:588–93.
31. Cleary G, Spalton DJ, Hancox J, et al. Randomized intraindividual comparison of posterior capsule opacification between a abdominal intraocular lens and a conventional intraocular lens. J Cataract Refract Surg. 2009; 35:265–72.
32. Cheng CY, Yen MY, Chen SJ, et al. Visual acuity and contrast sen-sitivity in different types of posterior capsule opacification. J Cataract Refract Surg. 2001; 27:1055–60.
crossref

Figure 1.
Posterior capsular opacification (PCO) scoring by slit lamp derived reflected light photographs and retroillumination. ‘Grade 0’ means ‘PCO do not intrude the intraocular lens (IOL) edge’. ‘Grade 1’ means ‘PCO intrude less than half of IOL edge area and below the continuous curvilinear capsulorrhexis (CCC) margin’. ‘Grade 2’ means ‘PCO intrude more than half of IOL edge area and below the CCC margin’. ‘Grade 3’ means ‘PCO intrude the CCC margin but do not intrude visual axis’, and ‘Grade 4’ means ‘PCO intrude visual axis’. ‘Visual axis' means ‘3 mm from center of pupil’.
jkos-57-1555f1.tif
Table 1.
Patient baseline characteristics in low and high fluid-dynamic parameter group
Characteristics Low Group High Group p-value*
Eyes 20 20  
Age (years) 68.71 ± 6.60 69.28 ± 6.25 0.421
Gender (male:female) 9:11 8:12  
Lens opacity      
   Nuclear opalescence 3.38 ± 0.72 3.43 ± 0.63 0.392
   Nuclear color 3.47 ± 0.68 3.52 ± 0.75 0.434
   Cortical 2.68 ± 1.25 2.37 ± 1.35 0.523
   Posterior subcapsular 1.52 ± 0.98 1.76 ± 1.12 0.621
BCVA (log MAR) 0.29 ± 0.35 0.20 ± 0.19 0.874
Endothelial cell density (cells/mm2) 2512.78 ± 281.78 2,538.36 ± 309.69 0.832

Values are presented as mean ± SD unless otherwise indicated.

BCVA = best corrected visual acuity.

* Mann-Whitney U-test.

Table 2.
Comparison of intraoperative parameters and outcomes
Exam Low Group (n = 20) High Group (n = 20) p-value*
Surgery time (seconds) 495.59 ± 82.79 476.62 ± 68.52 0.254
Ultrasound time (seconds) 64.31 ± 18.07 56.78 ± 24.85 0.249
Fluid consumption (mL) 107.50 ± 28.21 117.81 ± 35.50 0.459

Values are presented as mean ± SD unless otherwise indicated.

* Mann-Whitney U-test.

Table 3.
Comparison of postoperative BCVA
BCVA Low Group (n = 20) High Group (n = 20) p-value*
Preoperative 0.29 ± 0.35 0.20 ± 0.19 0.873
Postoperative      
   3 months 0.03 ± 0.01 0.02 ± 0.01 0.954
   6 months 0.05 ± 0.02 0.03 ± 0.01 0.932
   12 months 0.07 ± 0.02 0.05 ± 0.02 0.826

Values are presented as mean ± SD unless otherwise indicated.

BCVA = best corrected visual acuity (log MAR).

* Mann-Whitney U-test.

Table 4.
Preoperative and postoperative ECD and change in ECD
ECD Low Group (n = 20) High Group (n = 20) p-value*
Preoperative (cells/mm2) 2,512.78 ± 281.78 2,538.36 ± 309.69 0.785
Postoperative 12 months (cells/mm2) 2,297.45 ± 268.87 2,316.87 ± 287.36 0.842
Mean change (%) 7.79 ± 5.72 7.82 ± 4.89 0.674

Values are presented as mean ± SD unless otherwise indicated.

ECD = endothelial cell density (cells/mm2).

* Mann-Whitney U-test

Comparison of ECD change between groups.

Table 5.
Comparison of postoperative PCO score, percentage, and severity
PCO Low Group (n = 20) High Group (n = 20) p-value§
PCO score*      
   Postop 3 m 1.75 ± 0.62 1.00 ± 0.76 0.012
   Postop 6 m 1.82 ± 0.54 1.05 ± 0.91 0.035
   Postop 12 m 2.01 ± 0.55 1.23 ± 0.59 0.009
PCO percentage      
   Postop 3 m 28.23 ± 6.24 19.90 ± 6.09 <0.001
   Postop 6 m 36.82 ± 5.08 27.48 ± 5.99 0.023
   Postop 12 m 41.45 ± 7.30 36.45 ± 6.06 0.009
PCO severity      
   Postop 3 m 0.29 ± 0.08 0.22 ± 0.07 0.031
   Postop 6 m 0.35 ± 0.06 0.26 ± 0.04 0.048
   Postop 12 m 0.40 ± 0.05 0.34 ± 0.04 0.043

Values are presented as mean ± SD unless otherwise indicated.

PCO = posterior capsular opacification; Postop = postoperative; m = months.

* PCO score ranged from 0 to 4

PCO percentage ranged from 0 to 100

PCO severity ranged from 0 (totally clear) to 3 (total severe opacification)

§ Mann-Whitney U-test.

TOOLS
Similar articles